Advent International to acquire stake in Felix Pharmaceuticals
Advent International, a leading global private equity investor, signed a definitive agreement to invest $175 million via primary and secondary for a significant minority stake in Dublin-headquartered Felix Pharmaceuticals, a leading global generic animal pharma player, stated a company release. Felix Pharma is a manufacturer of off-patent medicines for companion animals.
Felix develops, manufactures and supplies to distributors and other branded generic players for private labelling, particularly in the US. With a portfolio of 14 approved products from USFDA and many more under review and development, Felix has the widest portfolio of products in the industry.
'Felix is well positioned to lead this generic space with its strong leadership, broad portfolio, and robust R&D and commercial capabilities. Its rapid growth and high customer satisfaction make it a differentiated platform, and we are excited to support Neeraj and the Felix team in scaling it into a global franchise,' said Shweta Jalan, Managing Partner at Advent.
Felix was founded in 2015 by Neeraj Agrawal, Sir Jonathan Symonds and Dr Shumeet Banerji, ex-CEO of Booz-Allen. While the company achieved its first US FDA approval in 2020, marking a pivotal step in its expansion, it has quickly scaled to a 14 commercialised product portfolio and has several others in advanced stages of pipeline, it said. It has a USFDA approved oral solid facility dedicated for animal health products and an injectable facility that is expected to be ready by Q3 2025. Neeraj Agrawal, Co-Founder of Felix Pharma, said, 'As we scale in a fast-evolving market, we were looking for a partner who brings not just capital, but also deep operating expertise and the right mindset and networks to help us grow faster and stronger.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Manipal Health Enterprises leads race to buy Sahyadri Hospitals with Rs 6,838 crore bid
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel IPO-bound Manipal Health Enterprises is leading the race to acquire Sahyadri Hospitals with a Rs 6,838 crore ($800 million) bid, people familiar with the matter said. It is trailed closely by Blackstone , they the sources did not reveal the financial terms of the global investment firm's offer, the strong interest in the Pune-headquartered hospital chain owned by Canada's pension fund Ontario Teachers' Pension Plan (OTPP) is symptomatic of the high-intensity consolidation ongoing in India's hospital space. IHH Healthcare-backed Fortis Healthcare and EQT Partners also submitted bids on June 23, which was the last day to submit binding financial offers were termed 'uncompetitive' by people ET spoke with. Manipal, Blackstone, Fortis and OTPP declined to comment. EQT did not responded to ET's queries until press time acquired Sahyadri from Everstone Capital in August 2022 at a valuation of around Rs 2,500 crore, outbidding Max Healthcare. Everstone had bought the hospital chain three years earlier in 2019 from its founder, neurosurgeon Charudutt Apte, for about Rs 1,000 crore. ET first reported on December 6 last year that OTPP was planning to put Sahyadri Hospitals on the block. In May, ET reported that Manipal Health, Singapore's IHH Healthcare, Blackstone-owned hospital chain Quality Care India, KKR & Co and EQT Partners were among those that had submitted initial bids for Hospitals operates 11 facilities across Pune, Nashik, Ahilya Nagar and Karad, comprising 1,300 beds, 2,500 clinicians and 3,500 support staff, according to information available on its website. Sahyadri Hospitals is estimated to have posted Rs 210 crore in earnings before interest, tax, depreciation and amortisation on revenue of Rs 1,200 crore in FY25, said a fund manager at one of the bidding private equity Manipal Health, commonly known as Manipal Hospitals, the deal could provide a muchneeded strategic foothold in western India, where it currently lacks a significant presence. In June 2025, KKR invested $600 million in debt into the Manipal Group to support its accelerated expansion and corporate growth IPO-bound Manipal Hospitals, the second-largest hospital chain in India, has been on an aggressive acquisition spree. In 2023, it acquired an 84% stake in Kolkata-based AMRI Hospitals in a deal valued at Rs 2,400 crore. Two years earlier, it bought Columbia Asia's Indian operations for Rs 2,100 crore.
Deccan Herald
an hour ago
- Deccan Herald
Non-metros contributing 70% of our sales: BlueStar MD
Bengaluru: The aspirational middle class from tier 3,4 and 5 cities are the new consumers for home appliances company, BlueStar, which are contributing 70% of its sales, Managing Director B Thiragarajan told DH in an interview. 'We saw almost 70% of the sales in fiscal year 2025, as there is a penetration level and good amount of disposable income.,' he has been witnessing a rising demand for consumer goods, including electronics from non-metros as discretionary spending continues to rise. However, 2025 saw a distorted summer with early rain spells and erratic dampening the sales for consumer electronics companies. BlueStar, as the country's second largest player in air-conditioning, witnessed a degrowth of 25% in financial year 2024-25 (FY25) as compared to the previous year when it saw 57% growth. .The cooler than usual summer has hit the sales of several companies including talcum, ice cream, soft drink among others. The unusual weather has emerged as a new threat to India's 1.4 billion-strong market lately. .Despite this, the firm believes that the rest of the year will make up for the degrowth, particularly the festive season. 'If the summer has failed a full year, the growth will be there because subsequent seasons do well,' he added. Additionally, the company is investing in customer experience especially as quick commerce has been picking up pace. .The Mumbai-headquartered firm has been beefing up delivery on quick commerce platforms, given that it's increasingly becoming a way of life, especially in now, Blue Star had to slash production by as much as 25% between April and June, as it saw less buyers. .While workforce remains an issue for the home appliances firm with respect to demand, conforming to Bureau of Indian Standards (BIS) has created hurdles in the supply chain because of testing. BlueStar also sells commercial ACs, however, the market size continues to be very small. Presently, the commercial segment is one-tenth of the residential market size. .India experienced extreme weather events on 88% of days in 2024, in one or more parts of the country, as per data by Centre for Science and Environment and Down To Earth. Between 1993 and 2022, India lost about $180 billion to severe heat and rains, the Climate Risk Index 2025 report said. This climate change, essentially the extreme summer, has also been causing shortage in gig workers for quick commerce players like Zepto, Zomato, Swiggy among others.
Time of India
6 hours ago
- Time of India
BAT bets big on India again, as ITC seeks to expand tobacco trade deal
Kolkata: In a sign of improved relations between ITC and its largest shareholder, British American Tobacco ( BAT ), the Indian company significantly grew the sale of raw tobacco to the London-headquartered cigarette maker in 2024-25 and received nearly double the amount in advances compared with the year before. BAT, popular for brands like Dunhill, Rothmans and Vuse, bought products (raw tobacco) for Rs 1,445 crore from ITC in FY25, up 35% from the previous year, as per ITC's latest annual report. The advances that ITC took from BAT increased to Rs 1,690 crore from Rs 881 crore in FY24. Advances between related parties are typically loans and other financial benefits. ITC did not specify on the type of the advance in the report. ITC, the country's largest exporter of raw tobacco, has also proposed to take shareholders' approval during the annual general meeting next month to expand its business with BAT. Under Indian regulations, related-party transactions that exceed Rs 1,000 crore or 10% of the annual consolidated turnover of a company require shareholder approval. ITC wants to take approval for raw tobacco export of up to Rs 2,320 crore by 2026-27. It is also seeking to buy '30 crore of raw international tobacco from BAT. ITC said in the annual report that it has been exporting un-manufactured tobacco to BAT for the past several years and the proposed transaction will aid the growth in business. BAT and ITC have a long bitter-sweet relation. In 2018, BAT vetoed a share-rewards programme for ITC employees. Around 2-3 decades back, BAT wanted to wrest ownership control of the Indian company but it was resisted by the then ITC chairman, KL Chugh. Chugh's successor, YC Deveshwar , worked hard to ensure that the stake held by SUUTI (Specified Undertaking of Unit Trust of India ) in ITC was not sold to BAT. He believed that BAT was only interested in tobacco and may reverse the diversification of ITC, a conglomerate with businesses ranging from paper products to FMCG and information technology. BAT's current chief executive, Tadeu Marroco, has recently said the company wanted to retain its veto rights in ITC. Last month, BAT sold a 2.5% stake in ITC for $1.5 billion (around Rs 12,926 crore), the proceeds of which the British company wanted to use to expand a share buyback programme. In 2024, BAT had sold 3.5% in ITC for about $2 billion. After those block deals, BAT now owns around 23% in ITC, making it the biggest shareholder, followed by Life Insurance Corporation of India which owns 15.5%. ITC has no promoter holding. BAT's Marroco had told analysts earlier this month that the company's stake in ITC was "still a strategic investment" and "not a financial investment". He said BAT was attracted by the size of the Indian market, demographics and potential GDP per capita growth. BAT has some inter-party relations with ITC in leaf and IT, he had said. "We want to preserve, as a consequence, a relevant stake in ITC. So we keep our two board directors, so we have influence on the board ... Obviously there was an opportunity now to increase the buyback," Marroco had said. BAT also owns a 15.3% stake in ITC Hotels, which it has indicated would exit at an opportune time since the hotel business is not the company's focus area.
